One adequately-powered human trial, plus supportive in-vitro / animal data. Effect plausible, not yet replicated.
| # | Compound | Category | EU Status | Last reviewed |
|---|---|---|---|---|
| 001. | Cagrilintide INN · cagrilintidum Long-acting amylin receptor agonist · weekly subcutaneous · investigational | Metabolic | NOT AUTHORISED | 18 MAY 2026 |
| 002. | GHK-Cu C₁₄H₂₃CuN₆O₄ · MW 405 Copper-bound tripeptide · skin-barrier modulator, wound-healing adjunct | Cosmetic | AUTHORISED | 18 MAY 2026 |
| 003. | Matrixyl 3000 INN · palmitoyl-tripeptide-1 Palmitoyl tripeptide-1 + tetrapeptide-7 · topical matrikine, MMP modulator | Cosmetic | AUTHORISED | 18 MAY 2026 |
| 004. | Mazdutide INN · mazdutidum Dual GLP-1 / glucagon receptor agonist · weekly subcutaneous · investigational | Metabolic | NOT AUTHORISED | 18 MAY 2026 |
| 005. | Melanotan-I INN · afamelanotidum Cyclic heptapeptide · selective α-MSH analogue · MC1R-preferential | Hormonal | AUTHORISED | 18 MAY 2026 |
| 006. | Retatrutide INN · retatrutidum Triple GLP-1 / GIP / glucagon receptor agonist · weekly subcutaneous · investigational | Metabolic | NOT AUTHORISED | 18 MAY 2026 |
| 007. | SS-31 INN · elamipretidum Cell-permeable tetrapeptide · cardiolipin-binding · mitochondrial-targeted | Longevity | NOT AUTHORISED | 18 MAY 2026 |
| 008. | Survodutide INN · survodutidum Dual GLP-1 / glucagon receptor agonist · weekly subcutaneous · investigational | Metabolic | NOT AUTHORISED | 18 MAY 2026 |
| 009. | Thymosin alpha-1 INN · thymalfasinum Acetylated 28-AA peptide · immunomodulator · enhances T-cell maturation | Recovery | NOT AUTHORISED | 18 MAY 2026 |